Neurana Pharmaceuticals is developing a novel, non-opioid, non-drowsy,

non-cognitive impairing treatment for acute and painful muscle spasms

NEURANA - 

Bringing new treatment options for muscle spasms

Neurana’s lead product, tolperisone, has a pharmacological profile that may offer unique benefits to patients suffering from muscle spasms

Put your cursor over years in the timeline to see the history of muscle spasm treatment options

TEAM

Visionary management and investors committed to reducing the pain and disability that can accompany acute muscle spasms